David McClung - Apr 14, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: Chief Financial Officer
Signature: /s/ David McClung
Stock symbol: BCDA
Transactions as of: Apr 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/18/2022, 09:17 PM
Previous filing: Jun 11, 2021
Next filing: Apr 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Award	$0	+50.3K	+107.56%	$0.00	97.2K	Apr 14, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA	Stock Option (right to buy)	Award	$0	+60K		$0.00	60K	Apr 14, 2022	Common Stock	60K	$1.49	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
F2	The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.